Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory process and provided nothing but risk and cost to Americans," Stanford ...

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

LOG Pharma has introduced a unified packaging solution, producing both bottles and caps at the same facility to enhance ...

LONDON/NEW YORK, April 1 (Reuters) - Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and ...

A short-term focus on corporation tax repatriation is a likely target of the Trump administration, owing to the complexity of ...

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

Research that spans therapeutic areas from cancer to mental health is currently in jeopardy following the Trump administration’s efforts to cut government spending in healthcare — and the cuts have ...

Steinkühler: AI presents a tremendous opportunity in the field of finance, primarily because it facilitates the use and ...